賽力斯(601127.SH):資產重組事項於1月21日上會
格隆匯1月14日丨賽力斯(601127.SH)公佈,公司擬發行股份購買重慶產業投資母基金合夥企業(有限合夥)、重慶兩江新區開發投資集團有限公司、重慶兩江新區產業發展集團有限公司持有的重慶兩江新區龍盛新能源科技有限責任公司100%股權(以下簡稱“本次交易”)。
根據上海證券交易所(以下簡稱“上交所”)併購重組審核委員會發布的《上海證券交易所併購重組審核委員會2025年第3次審議會議公吿》,上交所併購重組審核委員會定於2025年1月21日召開2025年第3次併購重組審核委員會審議會議,審核公司本次交易的申請。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.